Literature DB >> 21357766

Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies.

Dhohyung Kim1, Devra Huey, Michael Oglesbee, Stefan Niewiesk.   

Abstract

The inhibition of vaccination by maternal antibodies is a widely observed phenomenon in human and veterinary medicine. Maternal antibodies are known to suppress the B-cell response. This is similar to antibody feedback mechanism studies where passively transferred antibody inhibits the B-cell response against particulate antigens because of epitope masking. In the absence of experimental data addressing the mechanism underlying inhibition by maternal antibodies, it has been suggested that epitope masking explains the inhibition by maternal antibodies, too. Here we report that in the cotton rat model of measles virus (MV) vaccination passively transferred MV-specific immunoglobulin G inhibit B-cell responses through cross-linking of the B-cell receptor with FcγRIIB. The extent of inhibition increases with the number of antibodies engaging FcγRIIB and depends on the Fc region of antibody and its isotype. This inhibition can be partially overcome by injection of MV-specific monoclonal IgM antibody. IgM stimulates the B-cell directly through cross-linking the B-cell receptor via complement protein 3d and antigen to the complement receptor 2 signaling complex. These data demonstrate that maternal antibodies inhibit B-cell responses by interaction with the inhibitory/regulatory FcγRIIB receptor and not through epitope masking.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357766      PMCID: PMC3122939          DOI: 10.1182/blood-2010-11-320317

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  FcR gamma chain deletion results in pleiotrophic effector cell defects.

Authors:  T Takai; M Li; D Sylvestre; R Clynes; J V Ravetch
Journal:  Cell       Date:  1994-02-11       Impact factor: 41.582

2.  Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal antihapten antibodies of various isotypes.

Authors:  M Brüggemann; K Rajewsky
Journal:  Cell Immunol       Date:  1982-08       Impact factor: 4.868

3.  Dual immunoregulatory effects of monoclonal IgG-antibodies: suppression and enhancement of the antibody response.

Authors:  E J Wiersma; P G Coulie; B Heyman
Journal:  Scand J Immunol       Date:  1989-04       Impact factor: 3.487

4.  Antibody-induced restriction of viral gene expression in measles encephalitis in rats.

Authors:  U G Liebert; S Schneider-Schaulies; K Baczko; V ter Meulen
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  Differing effects of monoclonal anti-hapten antibodies on humoral responses to soluble or particulate antigens.

Authors:  F Enriquez-Rincon; G G Klaus
Journal:  Immunology       Date:  1984-05       Impact factor: 7.397

6.  Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1.

Authors:  D D'Ambrosio; K L Hippen; S A Minskoff; I Mellman; G Pani; K A Siminovitch; J C Cambier
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

7.  Immunoregulation by monoclonal sheep erythrocyte-specific IgG antibodies: suppression is correlated to level of antigen binding and not to isotype.

Authors:  B Heyman; H Wigzell
Journal:  J Immunol       Date:  1984-03       Impact factor: 5.422

8.  Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression.

Authors:  B Heyman; M Nose; W O Weigle
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

9.  Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling.

Authors:  G Pani; M Kozlowski; J C Cambier; G B Mills; K A Siminovitch
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

10.  Rapid isolation of morbillivirus nucleocapsid for genomic RNA cDNA cloning and the production of specific core protein antisera.

Authors:  M Oglesbee; L Tatalick; S Ringler; J Rice; S Krakowka
Journal:  J Virol Methods       Date:  1989-06       Impact factor: 2.014

View more
  31 in total

Review 1.  Vaccination strategies to enhance immunity in neonates.

Authors:  Tobias R Kollmann; Arnaud Marchant; Sing Sing Way
Journal:  Science       Date:  2020-05-08       Impact factor: 47.728

2.  Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice.

Authors:  Elinor Willis; Norbert Pardi; Kaela Parkhouse; Barbara L Mui; Ying K Tam; Drew Weissman; Scott E Hensley
Journal:  Sci Transl Med       Date:  2020-01-08       Impact factor: 17.956

3.  Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels.

Authors:  Shaikh Meshbahuddin Ahmad; Jahangir Alam; Nure Alam Afsar; Nazmul Huda; Yearul Kabir; Firdausi Qadri; Rubhana Raqib; Charles B Stephensen
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

4.  Inhibition of priming for bovine respiratory syncytial virus-specific protective immune responses following parenteral vaccination of passively immune calves.

Authors:  John Ellis; Sheryl Gow; Michael Bolton; William Burdett; Scott Nordstrom
Journal:  Can Vet J       Date:  2014-12       Impact factor: 1.008

5.  Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model.

Authors:  Bart G Jones; Robert E Sealy; Sherri L Surman; Allen Portner; Charles J Russell; Karen S Slobod; Philip R Dormitzer; John DeVincenzo; Julia L Hurwitz
Journal:  Vaccine       Date:  2014-04-14       Impact factor: 3.641

Review 6.  Maternal vaccination: moving the science forward.

Authors:  Azure N Faucette; Benjamin L Unger; Bernard Gonik; Kang Chen
Journal:  Hum Reprod Update       Date:  2014-07-11       Impact factor: 15.610

7.  Synergistic induction of interferon α through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats.

Authors:  Dhohyung Kim; Stefan Niewiesk
Journal:  Vaccine       Date:  2013-11-18       Impact factor: 3.641

8.  The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.

Authors:  William E O'Gorman; Huang Huang; Yu-Ling Wei; Kara L Davis; Michael D Leipold; Sean C Bendall; Brian A Kidd; Cornelia L Dekker; Holden T Maecker; Yueh-Hsiu Chien; Mark M Davis
Journal:  Vaccine       Date:  2014-09-06       Impact factor: 3.641

Review 9.  Transfer of maternal immunity and programming of the newborn immune system.

Authors:  Madeleine F Jennewein; Bahaa Abu-Raya; Yiwei Jiang; Galit Alter; Arnaud Marchant
Journal:  Semin Immunopathol       Date:  2017-10-02       Impact factor: 9.623

10.  The Effect of Tetanus-Diphtheria-Acellular-Pertussis Immunization During Pregnancy on Infant Antibody Responses: Individual-Participant Data Meta-Analysis.

Authors:  Bahaa Abu-Raya; Kirsten Maertens; Flor M Munoz; Petra Zimmermann; Nigel Curtis; Scott A Halperin; Nynke Rots; Daan Barug; Beth Holder; Beate Kampmann; Elke Leuridan; Manish Sadarangani
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.